BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 26640943)

  • 1. Diagnosis, Differential Diagnosis, and Epidemiology of Primary Sclerosing Cholangitis.
    Ponsioen CY
    Dig Dis; 2015; 33 Suppl 2():134-9. PubMed ID: 26640943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geoepidemiology of primary sclerosing cholangitis: a critical review.
    Tanaka A; Takikawa H
    J Autoimmun; 2013 Oct; 46():35-40. PubMed ID: 23932346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
    de Vries AB; Janse M; Blokzijl H; Weersma RK
    World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
    Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B
    Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of imaging criteria for distinguishing autoimmune cholangiopathy from primary sclerosing cholangitis and bile duct malignancy.
    Gardner CS; Bashir MR; Marin D; Nelson RC; Choudhury KR; Ho LM
    Abdom Imaging; 2015 Oct; 40(8):3052-61. PubMed ID: 26350286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of IgG4 in bile: a new approach for the diagnosis of IgG4-associated cholangiopathy.
    Vosskuhl K; Negm AA; Framke T; Weismüller T; Manns MP; Wedemeyer H; Plentz RR; Wedemeyer J; Lankisch TO
    Endoscopy; 2012 Jan; 44(1):48-52. PubMed ID: 22198775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A contribution to the differential diagnostics of sclerosing cholangitides].
    Blaho M; Dítě P; Bojková M; Rydlo M; Kupka T; Svoboda P; Klvaňa P; Martínek A
    Vnitr Lek; 2017; 63(1):50-55. PubMed ID: 28225291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review.
    Song J; Li Y; Bowlus CL; Yang G; Leung PSC; Gershwin ME
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):134-149. PubMed ID: 31463807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma.
    Oh HC; Kim MH; Lee KT; Lee JK; Moon SH; Song TJ; Eum J; Park DH; Lee SS; Seo DW; Lee SK
    J Gastroenterol Hepatol; 2010 Dec; 25(12):1831-7. PubMed ID: 21091993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
    Weismüller TJ; Trivedi PJ; Bergquist A; Imam M; Lenzen H; Ponsioen CY; Holm K; Gotthardt D; Färkkilä MA; Marschall HU; Thorburn D; Weersma RK; Fevery J; Mueller T; Chazouillères O; Schulze K; Lazaridis KN; Almer S; Pereira SP; Levy C; Mason A; Naess S; Bowlus CL; Floreani A; Halilbasic E; Yimam KK; Milkiewicz P; Beuers U; Huynh DK; Pares A; Manser CN; Dalekos GN; Eksteen B; Invernizzi P; Berg CP; Kirchner GI; Sarrazin C; Zimmer V; Fabris L; Braun F; Marzioni M; Juran BD; Said K; Rupp C; Jokelainen K; Benito de Valle M; Saffioti F; Cheung A; Trauner M; Schramm C; Chapman RW; Karlsen TH; Schrumpf E; Strassburg CP; Manns MP; Lindor KD; Hirschfield GM; Hansen BE; Boberg KM;
    Gastroenterology; 2017 Jun; 152(8):1975-1984.e8. PubMed ID: 28274849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.
    Fevery J; Van Steenbergen W; Van Pelt J; Laleman W; Hoffman I; Geboes K; Vermeire S; Nevens F
    Aliment Pharmacol Ther; 2016 Mar; 43(5):612-20. PubMed ID: 26748470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary sclerosing cholangitis].
    Boonstra K; Ponsioen CI; Rauws EA; Beuers U
    Ned Tijdschr Geneeskd; 2010; 154():A1476. PubMed ID: 20619015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options.
    Franceschet I; Cazzagon N; Del Ross T; D'Incà R; Buja A; Floreani A
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):508-13. PubMed ID: 26872110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary sclerosing cholangitis: a clinical update.
    Williamson KD; Chapman RW
    Br Med Bull; 2015 Jun; 114(1):53-64. PubMed ID: 25981516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study.
    Guerra I; Bujanda L; Castro J; Merino O; Tosca J; Camps B; Gutiérrez A; Gordillo Ábalos J; de Castro L; Iborra M; Carbajo AY; Taxonera C; Rodríguez-Lago I; Mesonero F; de Francisco R; Gómez-Gómez GJ; Chaparro M; Tardillo CA; Rivero M; Algaba A; Martín Arranz E; Cañete F; Vicente R; Sicilia B; Antolín B; Prieto V; Márquez L; Benítez JM; Camo P; Piqueras M; Gargallo CJ; Hinojosa E; Huguet JM; Pérez Calle JL; Van Domselaar M; Rodriguez C; Calvet X; Muñoz-Villafranca C; García-Sepulcre MF; Munoz-Garrido P; Fernández-Clotet A; Gómez Irwin L; Hernández S; Guardiola J; Sempere L; González Muñoza C; Hernández V; Beltrán B; Barrio J; Alba C; Moraleja I; López-Sanromán A; Riestra S; Martínez Montiel P; Garre A; Arranz L; García MJ; Martín Arranz MD; Corsino P; Arias L; Fernández-Salazar L; Fernández-Pordomingo A; Andreu M; Iglesias E; Ber Y; Mena R; Arroyo Villarino MT; Mora M; Ruiz L; López-Serrano P; Blazquez I; Villoria A; Fernández M; Bermejo F; Banales JM; Domènech E; Gisbert JP;
    J Crohns Colitis; 2019 Dec; 13(12):1492-1500. PubMed ID: 31063540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of inflammatory bowel disease among patients with primary sclerosing cholangitis in Iran.
    Hadizadeh M; Abedi SH; Malekpour H; Radinnia E; Jabbehdari S; Padashi M; Zali MR; Mohammad Alizadeh AH
    Arab J Gastroenterol; 2016 Mar; 17(1):17-9. PubMed ID: 27032493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis.
    Kaplan GG; Laupland KB; Butzner D; Urbanski SJ; Lee SS
    Am J Gastroenterol; 2007 May; 102(5):1042-9. PubMed ID: 17313496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis.
    Boonstra K; Weersma RK; van Erpecum KJ; Rauws EA; Spanier BW; Poen AC; van Nieuwkerk KM; Drenth JP; Witteman BJ; Tuynman HA; Naber AH; Kingma PJ; van Buuren HR; van Hoek B; Vleggaar FP; van Geloven N; Beuers U; Ponsioen CY;
    Hepatology; 2013 Dec; 58(6):2045-55. PubMed ID: 23775876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cholestatic liver diseases].
    Grimm D; Thimme R
    Ther Umsch; 2011 Apr; 68(4):195-9. PubMed ID: 21452140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin G4-related cholangitis: a variant of IgG4-related systemic disease.
    Novotný I; Dítě P; Trna J; Lata J; Husová L; Geryk E
    Dig Dis; 2012; 30(2):216-9. PubMed ID: 22722442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.